Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration

Antiviral Therapy

Volumn 11, Issue 5, 2006, Pages 641-645

  Jaroszewicz, Jerzy ^a   Wiercinska Drapalo, Alicja ^a   Lapinski, Tadeusz W ^a   Prokopowicz, Danuta ^a   Rogalska, Magdalena ^a   Parfieniuk, Anna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UREA;

ADULT; ARTICLE; BODY MASS; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TREATMENT DURATION; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; CYSTATINS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; VIRAL LOAD;

EID: 33747751600     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Schoenfeld P, Feduska NJ. Acquired immunodeficiency syndrome and renal disease: report of the National Kidney Foundation-National Institutes of Health Task Force on AIDS and Kidney Disease. Am J Kidney Dis 1990; 16:14-25.
2. Gupta SK, Mamlin BW, Johnson CS, et al. Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol 2004; 61:1-6.
3. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66:1145-1152.
4. Cho ME, Kopp JB. HIV and the kidney: a status report after 20 years. Curr HIV/AIDS Rep 2004; 1:109-115.
5. Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998; 352:783-784.
6. Cosgrove CJ, Abu-Alfa AK, Perazella MA. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. Am J Med Sci 2002; 323:102-106.
7. Szczech LA, Edwards LJ, Sanders LL, et al. Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol 2002; 57:336-341.
8. Lucas GM, Eustace JA, Sozio S, et al. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004; 18:541-546.
9. Mauss S, Berger F, Schmutz G. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. AlDS 2005; 19:93-95.
10. Herget-Rosenthal S, Pietruck F, Volbracht L, Philipp T, Kribben A. Serum cystatin C a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clin Nephrol 2005; 64:41-46.
11. Grubb A, Bjork J, Lindstrom V, Sterner G, Bondesson P, Nyman U. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest 2005; 65:153-162.
12. Gabutti L, Ferrari N, Mombelli G, Marone C. Does cystatin C improve the precision of Cockcroft and Gault's creatinine clearance estimation? J Nephrol 2004; 17:673-678.
13. From the Centers for Disease Control and Prevention, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. J Am Med Assoc 1993; 269:729-730.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 16:461-470.
15. Artunc FH, Fischer IU, Risler T, Erley CM. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol 2005; 10:173-178.
16. Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005; 16:1404-1412.
17. Villa P, Jimenez M, Soriano MC, Manzanares J, Casasnovas P. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005; 9:R139-143.
18. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36:29-34.
19. Massey D. Commentary: clinical diagnostic use of cystatin C. J Clin Lab Anal 2004; 18:55-60.
20. Mendiluce A, Bustamante J, Martin D, et al. Cystatin C as a marker of renal function in kidney transplant patients. Transplant Proc 2005; 37:3844-3847.
21. Akbari A, Lepage N, Keely E, et al. Cystatin-C and beta trace protein as markers of renal function in pregnancy. BJOG 2005; 112:575-578.
22. Husain M, D'agati VD, He JC, Klotman ME, Klotman PE. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 2005; 18:1975-1980.
23. Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344:1979-1984.
24. Kimmel PL, VedBrat SS, Pierce PF, et al. Prevalence of viremia in human immunodeficiency virus-infected patients with renal disease. Arch Intern Med 1995; 155:1578-1584.
25. Izzedine H, Wirden M, Launay-Vacher V. Viral load and HIV-associated nephropathy. N Engl J Med 2005; 353:1072-1074.
26. Krawczyk CS, Holmberg SD, Moorman AC, Gardner LI, McGwin G Jr; HIV Outpatient Study Group. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 2004; 18:2171-2178.
27. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006; 69:399-405.